Sun continues to bolster its specialty pipeline—Tildrakizumab (Merck), Odomzo (Novartis), MM-II (Moebius), Seciera (Ocular), Elepsia/Xelpros (SPARC), BromSite/DexaSite (Insite), Absorica (Ranbaxy), and Dusa drug products. Sun announced that its ... Financial Express, 1 week ago
1 images for "dusa pharmaceuticals"
Photodynamic therapy (PDT), the practice of irradiating a photosensitizing agent to damage cells, has a broad—and growing—range of indications. In dermatology, PDT is used to target precancerous and cancerous lesions, reduce the redness of ...MedEsthetics Magazine, 4 days ago
Research and Markets - Global Actinic Keratosis Market Analysis - Trends, Technologies & Opportunities Report..
/PRNewswire/ -- Research and Markets has announced the addition of the "Global Actinic Keratosis Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2012 To 2022" ...ADVFN India, 2 months ago Global Actinic Keratosis Market Report 2012-2022 - Analysis, Technologies & Forecasts - Vendors: Apotex, Perrigo Company, Tolmar Pharmaceuticals - Research and Markets PharmiWeb, 2 months ago
on your WebpageAdd Widget >Get your members hooked!